THE FACE DOCTOR LIMITED - Period Ending 2023-07-31

THE FACE DOCTOR LIMITED - Period Ending 2023-07-31


THE FACE DOCTOR LIMITED 08594028 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is Retail sale of cosmetic and toilet arti Digita Accounts Production Advanced 6.30.9574.0 true true 08594028 2022-08-01 2023-07-31 08594028 2023-07-31 08594028 core:CurrentFinancialInstruments 2023-07-31 08594028 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 08594028 core:Non-currentFinancialInstruments 2023-07-31 08594028 core:Non-currentFinancialInstruments core:AfterOneYear 2023-07-31 08594028 bus:SmallEntities 2022-08-01 2023-07-31 08594028 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 08594028 bus:FullAccounts 2022-08-01 2023-07-31 08594028 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 08594028 bus:RegisteredOffice 2022-08-01 2023-07-31 08594028 bus:Director2 2022-08-01 2023-07-31 08594028 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 08594028 countries:UnitedKingdom 2022-08-01 2023-07-31 08594028 2021-08-01 2022-07-31 08594028 2022-07-31 08594028 core:CurrentFinancialInstruments 2022-07-31 08594028 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 08594028 core:Non-currentFinancialInstruments 2022-07-31 08594028 core:Non-currentFinancialInstruments core:AfterOneYear 2022-07-31 iso4217:GBP xbrli:pure

Registration number: 08594028

THE FACE DOCTOR LIMITED

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2023

 

THE FACE DOCTOR LIMITED

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 6

 

THE FACE DOCTOR LIMITED

Company Information

Director

Dr Andrew Paul Gorman

Registered office

30 Carmichael Mews
London
London
England
SW18 3HJ

Accountants

R S Business Consulting Ltd
Chartered Certified Accountants
11 Approach Road
Raynes Park
London
SW20 8BA

 

THE FACE DOCTOR LIMITED

(Registration number: 08594028)
Balance Sheet as at 31 July 2023

Note

2023
£

2022
£

Current assets

 

Debtors

5

10,657

230

Cash at bank and in hand

 

1,477

1,287

 

12,134

1,517

Creditors: Amounts falling due within one year

6

(229,839)

(44,580)

Total assets less current liabilities

 

(217,705)

(43,063)

Creditors: Amounts falling due after more than one year

6

165,808

(82,874)

Net liabilities

 

(51,897)

(125,937)

Capital and reserves

 

Called up share capital

10

10

Retained earnings

(51,907)

(125,947)

Shareholders' deficit

 

(51,897)

(125,937)

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 8 March 2024
 

.........................................
Dr Andrew Paul Gorman
Director

 

THE FACE DOCTOR LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
30 Carmichael Mews
London
London
England
SW18 3HJ

These financial statements were authorised for issue by the director on 8 March 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

THE FACE DOCTOR LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

 

THE FACE DOCTOR LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

4

Tangible assets

Cost or valuation

Depreciation

Carrying amount

At 31 July 2023

5

Debtors

Current

2023
£

2022
£

Trade debtors

8,862

230

Other debtors

1,795

-

 

10,657

230

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Trade creditors

25,732

27,542

Taxation and social security

-

13,188

Accruals and deferred income

3,838

3,850

Other creditors

200,269

-

229,839

44,580

Creditors: amounts falling due after more than one year

Note

2023
£

2022
£

Due after one year

 

Loans and borrowings

7

(165,808)

82,874

 

THE FACE DOCTOR LIMITED

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2023

7

Loans and borrowings

2023
£

2022
£

Non-current loans and borrowings

Bank borrowings

-

713

Other borrowings

(165,808)

82,161

(165,808)

82,874